X0206 3 2016-03-22 0 0001626971 Corvus Pharmaceuticals, Inc. CRVS 0001031847 MILLER RICHARD A MD C/O CORVUS PHARMACEUTICALS, INC. 863 MITTEN ROAD, SUITE 102 BURLINGAME CA 94010 1 1 0 0 President and CEO Common Stock, $0.0001 par value 718228 I By Trust Series A Convertible Preferred Stock 0.00 Common Stock 266310 I By Trust Series B Convertible Preferred Stock 0.0 Common Stock 62455 I By Trust A portion of these shares is subject to a right of repurchase held by the Issuer. These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller-Horning Trust. The Series A Convertible Preferred Stock and Series B Convertible Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of Issuer's initial public offering. The expiration date is not relevant to the conversion of these securities. /s/ Leiv Lea, as Attorney-in-Fact for Richard A. Miller 2016-03-22